Geneos Wealth Management Inc. XPND FIRST TR EXCHNG TRADED FD VI

Ownership history in Geneos Wealth Management Inc.  ·  9 quarters on record

AI Ownership Summary

Geneos Wealth Management Inc. reported FIRST TR EXCHNG TRADED FD VI (XPND) in 9 quarterly 13F filings from 2024 Q1 through 2026 Q1. Peak portfolio weight reached 0.01% in 2024 Q1. The latest visible filing shows XPND at 0.00% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings.

What this XPND ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was Geneos Wealth Management Inc.'s position in FIRST TR EXCHNG TRADED FD VI, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2026 Q1

XPND was reported at 0.00% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
0.01% in 2024 Q1

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2024 Q1 to 2026 Q1

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

How Geneos Wealth Management Inc. held XPND — position size vs. price
% of Fund (quarterly)    XPND price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 9 quarters  
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2026 Q1 ADDED 5,064 +180 +3.7% 0.00% $166K 2026-05-05 $37.61
2025 Q4 UNCHANGED 4,884 0% 0.00% $176K 2026-01-28 $36.05
2025 Q3 ADDED 4,884 +1,656 +51.3% 0.00% $177K 2025-10-22 $36.68
2025 Q2 REDUCED 11.7% +7.5% 3,228 -426 -11.7% 0.00% $109K 2025-08-18 $34.29
2025 Q1 REDUCED 31.9% +19.4% 3,654 -1,711 -31.9% 0.00% $103K 2025-05-08 $29.77
2024 Q4 REDUCED 12.0% -7.2% 5,365 -733 -12.0% 0.01% $163K 2025-01-21 $31.23
2024 Q3 REDUCED 10.6% +6.8% 6,098 -723 -10.6% 0.01% $175K 2024-11-14 $30.57
2024 Q2 REDUCED 11.3% +2.2% 6,821 -871 -11.3% 0.01% $192K 2024-07-23 $27.59
2024 Q1 INITIATED 7,692 0.01% $204K 2024-05-03 $25.53

FAQ About Geneos Wealth Management Inc. and XPND

These are the practical questions this page is built to answer before you even open the full history table.

How long has Geneos Wealth Management Inc. reported owning XPND?

Geneos Wealth Management Inc. reported XPND across 9 quarterly 13F filings, from 2024 Q1 through 2026 Q1.

What was the largest reported XPND position in Geneos Wealth Management Inc.'s portfolio?

The largest reported portfolio weight for XPND was 0.01% in 2024 Q1.

What is the latest reported XPND position on this page?

The most recent filing on this page is 2026 Q1, when Geneos Wealth Management Inc. reported 5,064 shares, equal to 0.00% of portfolio, with an estimated market value of $166K.

What does the chart on this XPND ownership page compare?

The chart compares Geneos Wealth Management Inc.'s quarterly XPND portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

How well did Geneos Wealth Management Inc. time their XPND position?

Based on 13F filing dates vs. subsequent XPND price moves, Geneos Wealth Management Inc. correctly timed 2 out of 7 reported position changes (29%). The annualised alpha on XPND relative to SPY over the holding period was +18.6%.

← Back to Geneos Wealth Management Inc. Holdings